ImmunoRad 2024: Primer on Radiation Therapy-Induced Modulation of the Tumor Immune Microenvironment

When:  Oct 3, 2024 from 10:30 to 12:30 (ET)

This program is provided by Weill Cornell, in collaboration with the Society for Immunotherapy of Cancer (SITC).

The Primer Session on Radiation Therapy-Induced Modulation of the Tumor Immune Microenvironment will be held on October 3, 2024 and is part of the 8th International Conference on Immunotherapy Radiotherapy Combinations from October 3 - 5, 2024. This session is CME-accredited.

10:30 – 11 a.m.

Novel Strategies to Addressing Checkpoint Resistance
James W. Welsh, MD - MD Anderson Cancer Center, Houston, TX, USA

11 – 11:30 a.m.

Low-dose RT as Strategy to Recruit T Cells to the Tumor Microenvironment
Fernanda Herrera, MD, PhD - Universite de Lausanne, Lausanne, Switzerland

11:30 a.m. – 12 p.m.

Impact of Intestinal Low Dose Irradiation in response to
immunoradiotherapy
Eric Deutsch, MD - Gustave Roussy Cancer Center, Paris, France

12 – 12:30 p.m.

Emerging effects of radiation therapy on lymphocytes
Lorenzo Gallluzzi, PhD - Weill Cornell Medical College, New York, NY, USA


For more information, or to register, please click here.

Location

Weill Cornell Medical College
1300 York Avenue
New York, NY 10065